Invitae Receives Court Approval for Sale to Labcorp

Acquisition advances Labcorp's specialty testing strategy in key areas such as oncology and rare diseases Key milestone reached in Invitae's Chapter 11 process BURLINGTON, N.C. and SAN FRANCISCO , May 7, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive

Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B

Assay expands company's leadership in precision medicine and cell and gene therapy BURLINGTON, N.C. , April 29, 2024 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the U.S. Food and Drug Administration (FDA) has approved its

Labcorp Announces 2024 First Quarter Results

Updates Full-Year Guidance Results from Continuing Operations for first quarter 2024 versus last year: Revenue: $3.18 billion versus $3.04 billion or up 4.6% | Base Business grew 6.7% Diluted EPS: $2.69 versus $2.34 Adjusted EPS: $3.68 versus $3.46 Full-Year 2024 Guidance: Raised midpoint and

Labcorp Announces Winning Bid for Select Assets of Invitae

Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 BURLINGTON, N.C. , April 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and

Labcorp Finalizes Acquisition of Providence's Outreach Laboratory Business in Northern California and Orange County

Agreement includes ambulatory lab draw stations and an ambulatory laboratory facility;aims to provide broader access to comprehensive testing and laboratory services for patients and physicians

Labcorp and Baystate Health Finalize Strategic Relationship For Diagnostics Services

Labcorp acquires Baystate Health’s outreach laboratory business and select operating assetsCollaboration to improve access and enhance affordable, high-quality healthcare services for underserved communities across Massachusetts 

Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw

Innovative GFAP blood biomarker test expands Labcorp's portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C. , April 15, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C. , April 11, 2024 /PRNewswire/ -- Labcorp  (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 12, 2024 , to

Labcorp Publishes 2023 Corporate Responsibility Report

Highlights include progress on initiatives aimed at protecting the environment, cultivating a skilled and diverse workforce and expanding health access to underserved communities

Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit

The first at-home mpox testing kit provides patients with convenience and privacy to test for mpox, supports physicians in detection and treatment BURLINGTON, N.C. , April 10, 2024 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced